NVR 7P5 (Afinitor 7.5 mg)

Generic Name: everolimus

Pill imprint NVR 7P5 has been identified as Afinitor 7.5 mg.

Afinitor is used in the treatment of breast cancer; renal cell carcinoma; brain tumor; pancreatic cancer; renal angiomyolipoma (and more), and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor 7.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for NVR 7P5

Afinitor
Generic Name:
everolimus
Imprint:
NVR
7P5
Strength:
7.5 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
MTOR inhibitors
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0620
Inactive Ingredients:
butylated hydroxytoluene
crospovidone
hypromelloses
lactose anhydrous
lactose monohydrate
magnesium stearate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)